Which are the causes of Dysautonomia / POTS?

The exact cause of Dysautonomia, specifically Postural Orthostatic Tachycardia Syndrome (POTS), remains multifactorial and is currently not fully understood, as it often results from a complex interplay between genetic predisposition, immune system dysfunction, and environmental triggers.

Pathophysiology and Mechanisms

Think of the autonomic nervous system as the body’s internal "autopilot." In Dysautonomia / POTS, this autopilot struggles to maintain balance when you stand up. Research suggests several potential mechanisms:

• Autoimmune Processes: Many patients with Dysautonomia / POTS show evidence of autoantibodies that may interfere with the receptors responsible for regulating heart rate and blood vessel constriction.


• Hypovolemia: Some individuals have lower blood volume, making it harder for the heart to pump effectively against gravity.


• Neuropathic Factors: Small fiber neuropathy can damage the delicate nerves that signal blood vessels to tighten, leading to blood pooling in the lower extremities.

Genetic and Environmental Factors

While there is no single "POTS gene," clinical research indicates that Dysautonomia / POTS often clusters in families, suggesting a polygenic inheritance pattern where multiple small genetic variations increase susceptibility. Environmental triggers are also significant; a viral infection, a significant physical injury, or a period of severe physiological stress often acts as the "tipping point" that initiates symptoms in those already predisposed.

Current Research and Etiology

It is vital to distinguish between a "cause" (the direct biological driver) and a "risk factor" (a trait that makes someone more likely to develop the condition). For Dysautonomia / POTS, we are still working to map these distinctions. Current research is heavily focused on the role of the immune system and the potential for post-viral syndromes to trigger long-term autonomic instability. Because the condition manifests differently in every patient, scientists are working to categorize subtypes to better tailor treatments to the specific underlying mechanism rather than just managing symptoms.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Dysautonomia International


• Orphanet: The portal for rare diseases and orphan drugs


• National Institute of Neurological Disorders and Stroke (NINDS)